Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
CALL
Ferrari
RACE
$72.9B
| $14.3M | 0.01% |
83,500
-8,700
| -9% | -$1.4M |
|
1702
Haemonetics
HAE
$4.13B
| $14.3M | 0.01% |
159,390
+50,607
| +47% | +$5.11M |
|
1703
FS KKR Capital
FSK
$3.42B
| $14.3M | 0.01% |
1,018,233
+381,265
| +60% | +$5.37M |
|
1704
CALL
Neurocrine Biosciences
NBIX
$15.5B
| $14.2M | 0.01% |
116,600
+9,000
| +8% | +$995K |
|
1705
CALL
Vulcan Materials
VMC
$36.5B
| $14.2M | 0.01% |
122,600
+39,300
| +47% | +$4.3M |
|
|
MYOK
1706
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $14.2M | 0.01% |
146,932
+109,028
| +288% | +$9.09M |
|
1707
PUT
United States Natural Gas Fund
UNG
$487M
| $14.2M | 0.01% |
345,725
-386,825
| -53% | -$18.4M |
|
1708
PUT
Cardinal Health
CAH
$54.7B
| $14.2M | 0.01% |
271,700
+24,800
| +10% | +$1.28M |
|
1709
Papa John's
PZZA
$799M
| $14.2M | 0.01% |
178,262
-456,337
| -72% | -$33.9M |
|
1710
CALL
NetApp
NTAP
$40.6B
| $14.2M | 0.01% |
318,900
+69,500
| +28% | +$2.99M |
|
1711
CALL
Vanguard Morningstar Total Stock Market ETF
VTI
$695B
| $14.2M | 0.01% |
90,400
-4,800
| -5% | -$708K |
|
1712
Capri Holdings
CPRI
$1.74B
| $14.1M | 0.01% |
903,876
-2,931,701
| -76% | -$43.4M |
|
|
CZR
1713
DELISTED
Caesars Entertainment Corporation
CZR
| $14.1M | 0.01% |
1,162,111
-6,228,707
| -84% | -$62.9M |
|
1714
CALL
W.W. Grainger
GWW
$62.3B
| $14M | 0.01% |
44,700
-8,200
| -16% | -$2.37M |
|
1715
Armstrong World Industries
AWI
$7.7B
| $14M | 0.01% |
179,818
-97,677
| -35% | -$7.4M |
|
1716
CALL
iShares Core S&P 500 ETF
IVV
$908B
| $14M | 0.01% |
45,200
-39,200
| -46% | -$11.5M |
|
|
MRSN
1717
DELISTED
Mersana Therapeutics
MRSN
| $14M | 0.01% |
23,928
+5,481
| +30% | +$1.87M |
|
1718
CALL
Deckers Outdoor
DECK
$12.7B
| $14M | 0.01% |
427,200
+105,000
| +33% | +$2.89M |
|
1719
PUT
Johnson Controls International
JCI
$93.1B
| $14M | 0.01% |
409,100
+314,000
| +330% | +$9.66M |
|
1720
PUT
Cleveland-Cliffs
CLF
$6.79B
| $14M | 0.01% |
2,528,700
+1,004,600
| +66% | +$4.88M |
|
1721
Thermo Fisher Scientific
TMO
$218B
| $13.9M | 0.01% |
38,466
-350,677
| -90% | -$118M |
|
1722
GDS Holdings
GDS
$6.89B
| $13.9M | 0.01% |
174,937
-613,106
| -78% | -$37.9M |
|
1723
uniQure
QURE
$3.37B
| $13.9M | 0.01% |
308,945
+244,817
| +382% | +$14.5M |
|
1724
CALL
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$534M
| $13.9M | 0.01% |
126,000
+310
| +0.2% | +$26.1K |
|
1725
PUT
Equitable Holdings
EQH
$14.5B
| $13.9M | 0.01% |
+720,000
| New | +$12.9M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.